IDEX Corporation (IEX) - Q1 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2026. IDEX Corporation is an applied solutions provider specializing in Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The company operates globally, with significant exposure to industrial activity levels, currency fluctuations, and niche markets including data centers, semiconductors, and space/defense.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $886.9 million | $814.3 million |
| Operating Income | $172.4 million | $142.0 million |
| Net Income (Attributable to IDEX) | $120.0 million | $95.5 million |
| Diluted EPS | $1.61 | $1.26 |
| Adjusted EBITDA | $230.4 million | $208.0 million |
| Operating Cash Flow | $103.7 million | $105.7 million |
| Free Cash Flow | $86.0 million | $91.4 million |
| Total Debt (Long-term + Current) | $1,872.3 million | $1,820.8 million |
| Cash and Equivalents | $586.2 million | $612.2 million (end of Q1 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% year-over-year, driven by a 5% organic increase. Growth was led by the HST segment (+17% sales) due to higher volumes in data center, semiconductor, and space/defense markets.
- Profitability: Operating income rose 21% to $172.4 million. Diluted EPS increased 28% to $1.61. Gross margin decreased slightly by 40 basis points to 44.9% due to unfavorable mix, despite positive price/cost dynamics.
- Restructuring: Restructuring expenses and asset impairments decreased significantly to $7.4 million from $17.5 million in the prior year. The current quarter included $4.8 million in asset impairments within the FMT segment.
- Legal Settlement: The company recognized a $3.7 million gain on a legal settlement related to a patent infringement lawsuit, which was excluded from Adjusted EBITDA.
- Acquisitions: The impact of the Micro-LAM acquisition (completed July 2025) contributed to sales growth in the HST segment.
Guidance, Outlook, and Risks
- Capital Allocation: The company returned $129.1 million to shareholders in Q1 2026 via $76.3 million in share repurchases and $52.8 million in dividends. As of March 31, 2026, $849.7 million remained under share repurchase authorization.
- Liquidity: The company maintains a strong liquidity position with $517.2 million available under its $800 million Revolving Facility. Credit ratings remain stable (BBB/Baa2/BBB+).
- Tariffs and Trade: Following a U.S. Supreme Court ruling invalidating broad-based tariffs, new tariffs were implemented under alternative authority. Management states these did not materially impact Q1 2026 results but will continue to monitor for refunds and mitigation opportunities.
- Risks: Key risks include global economic conditions, supply chain disruptions, cybersecurity threats, and the impact of AI-driven market changes on customer demand.
Investor Verification Checklist
- Organic Growth Drivers: Verify the sustainability of volume growth in the HST segment, specifically regarding data center and semiconductor demand.
- Asset Impairments: Review the details of the $4.8 million impairment in the FMT segment to assess if it indicates broader asset valuation issues.
- Working Capital Trends: Monitor the increase in operating working capital ($52.8 million increase), driven by higher receivables and inventories, to ensure it aligns with sales growth and does not signal collection issues.
- Legal Settlement: Confirm the non-recurring nature of the $3.7 million legal settlement gain when evaluating future earnings.
- Debt Utilization: Track the utilization of the Revolving Facility, which increased by $51.3 million in the quarter to fund general corporate purposes and share repurchases.